title: Effects of pancreatic polypeptide on insulin action in exocrine secretion of isolated rat pancreas.
abstract: 1. Effects of pancreatic polypeptide (PP) on insulin action in pancreatic exocrine secretion was investigated by using an isolated rat pancreas that was perfused with Krebs-Henseleit solution containing 2.5 mM glucose, 0.1% bovine serum albumin and 3% Dextran T-70 at a vascular flow rate of 1.2 ml min-1. 2. Cholecystokinin-8 (CCK-8) at a concentration of 14 pM stimulated basal flow rate and amylase output of the isolated pancreas. Twenty-five millimolar glucose not only increased the basal flow rate and amylase output but also potentiated the CCK-stimulated flow rate and amylase output. 3. Porcine insulin, administered intra-arterially at a concentration of 100 nM, also increased the basal flow rate and amylase output, and also potentiated the CCK-stimulated flow rate and amylase output. 4. Rat PP, given intra-arterially at a concentration of 10 pM, completely abolished the potentiation effects of both the 25 mM glucose and the exogenous insulin on the CCK-stimulated flow rate and amylase output. Rat PP also inhibited the flow rate and amylase output increased by either 25 mM glucose alone or exogenous insulin alone. However, rat PP did not change the flow rate and amylase output stimulated by CCK-8 alone. 5. These results indicate that insulin is an important stimulatory hormone of pancreatic exocrine secretion, and that PP exerts the inhibitory role in pancreatic exocrine secretion by modulating the insulin action.
authors.affiliation: Department of Physiology, College of Medicine, Hallym University, Chunchon, Kangwon-Do, Korea.
authors.forename: H J
authors.initials: HJ
authors.lastname: Park
authors.forename: Y L
authors.initials: YL
authors.lastname: Lee
authors.forename: H Y
authors.initials: HY
authors.lastname: Kwon
mesh_terms: D000681:Amylases / Q000378:metabolism; D000818:Animals; D002766:Cholecystokinin / Q000494:pharmacology; D005947:Glucose / Q000494:pharmacology; D066298:In Vitro Techniques; D007328:Insulin / Q000494:pharmacology*; D008297:Male; D010179:Pancreas / Q000187:drug effects / Q000201:enzymology / Q000378:metabolism*; D010191:Pancreatic Polypeptide / Q000494:pharmacology*; D051381:Rats; D017207:Rats, Sprague-Dawley
chemical_list: D007328:Insulin; D010191:Pancreatic Polypeptide; D002766:Cholecystokinin; D000681:Amylases; D005947:Glucose